BioNTech SE (BNTX) Interest & Investment Income (2018 - 2025)

BioNTech SE has disclosed Interest & Investment Income across 8 years of filings, most recently posting $493.4 million for Q4 2025.

• Interest & Investment Income for Q4 2025 came in at $493.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $493.4 million (changed N/A YoY), and the FY2025 annual result was $478.9 million, down 32.5% from the prior year.
• Interest & Investment Income came in at $493.4 million for Q4 2025 at BioNTech SE, up from $379.7 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $547.8 million in Q3 2024 to a low of -$722562.9 in Q2 2021.
• The 5-year median for Interest & Investment Income is $281.7 million (2022), against an average of $271.7 million.
• Across the five-year window, Interest & Investment Income plunged 209.33% in 2021 and surged 57339.47% in 2022, its largest moves.
• BioNTech SE's Interest & Investment Income stood at $60.6 million in 2021, then soared by 646.03% to $452.2 million in 2022, then declined by 12.57% to $395.4 million in 2023, then jumped by 38.55% to $547.8 million in 2024, then slipped by 9.92% to $493.4 million in 2025.
• The last three Interest & Investment Income figures came in at $493.4 million (Q4 2025), $379.7 million (Q3 2025), and $258.1 million (Q2 2025), per Business Quant data.